Other conditions, such as Hodgkin’s lymphoma treated with radiotherapy or procarbazine-containing chemotherapy, can increase the frequency of MSI CRC with somatic MMR gene alterations [229]. The gene discussed is MRC1; the disease is colorectal carcinoma.